GLYC stock forecast
Our latest prediction for GlycoMimetics, Inc.'s stock price was made on the Sept. 5, 2019 when the stock price was at 3.32$.
In the short term (2weeks), GLYC's stock price should outperform the market by 6.84%. During that period the price should oscillate between -8.85% and +32.98%.
In the medium term (3months), GLYC's stock price should outperform the market by 5.80%. During that period the price should oscillate between -19.26% and +79.14%.Get email alerts
About GlycoMimetics, Inc.
GlycoMimetics, Inc. operates as a clinical stage biotechnology company, which focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease-related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -1.29$ per share.
The book value per share is 5.30$
Three months stock forecastSept. 5, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|